Bank of Nova Scotia’s Vir Biotechnology VIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-10,000
| Closed | -$253K | – | 1195 |
|
|
2022
Q4 | $253K | Sell |
10,000
-22,683
| -69% | -$574K | ﹤0.01% | 1066 |
|
|
2022
Q3 | $630K | Buy |
32,683
+3,133
| +11% | +$60.4K | ﹤0.01% | 921 |
|
|
2022
Q2 | $753K | Buy |
29,550
+5,189
| +21% | +$132K | ﹤0.01% | 899 |
|
|
2022
Q1 | $627K | Sell |
24,361
-9,940
| -29% | -$256K | ﹤0.01% | 1001 |
|
|
2021
Q4 | $1.51M | Buy |
34,301
+24,808
| +261% | +$1.09M | ﹤0.01% | 891 |
|
|
2021
Q3 | $413K | Sell |
9,493
-1,177
| -11% | -$51.2K | ﹤0.01% | 1002 |
|
|
2021
Q2 | $504K | Buy |
10,670
+3,442
| +48% | +$163K | ﹤0.01% | 942 |
|
|
2021
Q1 | $371K | Sell |
7,228
-12,712
| -64% | -$652K | ﹤0.01% | 972 |
|
|
2020
Q4 | $534K | Buy |
+19,940
| New | +$534K | ﹤0.01% | 863 |
|